FindTrial
Sign In

Effect of giving Zinc in Nephrotic Syndrome

Comparison of standard versus double duration of Zinc supplementation in children with Nephrotic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031908
Enrollment
70
Registered
2021-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

Intervention1: zinc: 20mg/day for 2 weeks in group 1 Control Intervention1: zinc: zinc 20mg/day for 4 weeks in group 2

Sponsors

MLN Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all new and relapse cases of steroid sensitive nephrotic syndrome

Exclusion criteria

Exclusion criteria: 1. patients with chronic debilitating illness 2. steroid resistant nephrotic syndrome 3. congenital malformation of genitourinary system 4. those who have taken Zinc in any form in previous 3 months 5. patients with signs of systemic infection

Design outcomes

Primary

MeasureTime frame
Compare the time duration to next relapse in those supplemental with Zinc for 2 weeks and in those supplemented for 4 weeksTimepoint: 1 year—

Secondary

MeasureTime frame
number of infective episodesTimepoint: 6 months;number of relapsesTimepoint: 6 months;time duration to attain remissionTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Amit Bagga

MLN Medical college

anubhashrivastava@rediffmail.com9236804326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026